{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:14:07Z","timestamp":1715386447503},"reference-count":10,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,5,31]]},"DOI":"10.1536\/ihj.22-752","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:12:06Z","timestamp":1684188726000},"page":"502-505","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Agalsidase Alfa Enzyme Replacement Therapy on Left Ventricular Hypertrophy on Electrocardiogram in a Female Patient with Fabry Disease"],"prefix":"10.1536","volume":"64","author":[{"given":"Kazufumi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"},{"name":"Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Takaya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Morinaga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"},{"name":"Department of Medicine, Kawasaki Medical School General Medical Center and Department of Medical Care Work, Kawasaki College of Allied Health Professions"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Germain DP, Elliott PM, Falissard B, <i>et al<\/i>. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. Mol Genet Metab Rep 2019; 19: 100454.","DOI":"10.1016\/j.ymgmr.2019.100471"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Azevedo O, Cordeiro F, Gago MF, <i>et al<\/i>. Fabry Disease and the Heart: A Comprehensive Review. Int J Mol Sci 2021; 22: 22094434.","DOI":"10.3390\/ijms22094434"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hughes DA, Elliott PM, Shah J, <i>et al<\/i>. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 2008; 94: 153-8.","DOI":"10.1136\/hrt.2006.104026"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Germain DP, Weidemann F, Abiose A, <i>et al<\/i>. Analysis of left ventricular mass in untreated men and in men treated with agalsidase-beta: data from the Fabry Registry. Genet Med 2013; 15: 958-65.","DOI":"10.1038\/gim.2013.53"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kampmann C, Linhart A, Baehner F, <i>et al<\/i>. Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int J Cardiol 2008; 130: 367-73.","DOI":"10.1016\/j.ijcard.2008.03.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Linhart A, Palecek T, Bultas J, <i>et al<\/i>. New insights in cardiac structural changes in patients with Fabry&apos;s disease. Am Heart J 2000; 139: 1101-8.","DOI":"10.1067\/mhj.2000.105105"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Schiffmann R, Kopp JB, Austin HA 3rd, <i>et al<\/i>. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 2743-9.","DOI":"10.1001\/jama.285.21.2743"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Motwani M, Banypersad S, Woolfson P, Waldek S. Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Mol Genet Metab 2012; 107: 197-202.","DOI":"10.1016\/j.ymgme.2012.05.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vitale G, Ditaranto R, Graziani F, <i>et al<\/i>. Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy. Heart 2022; 108: 54-60.","DOI":"10.1136\/heartjnl-2020-318271"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Beer M, Weidemann F, Breunig F, <i>et al<\/i>. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry&apos;s cardiomyopathy. Am J Cardiol 2006; 97: 1515-8.","DOI":"10.1016\/j.amjcard.2005.11.087"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/3\/64_22-752\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:06:42Z","timestamp":1715317602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/3\/64_22-752\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-752","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"article-number":"22-752"}}